[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f9mVU41-0KVWT3e4e4L5n71hfSNZpJ280WIDv99Nq83w":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":58,"rows":65},"Bandim Health Project",[4],59,false,5,3,1308633,4,12,[14,17,19,22,25,27,29,31],{"name":15,"count":16},"Mortality",13,{"name":18,"count":16},"Morbidity",{"name":20,"count":21},"Malaria",8,{"name":23,"count":24},"Measles",7,{"name":26,"count":8},"Infant Mortality",{"name":28,"count":9},"Malaria, Falciparum",{"name":30,"count":9},"Non-specific Effects of Vaccines",{"name":32,"count":9},"Heterologous Immunity",[34,39,44,49,53],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT04899765","Measles and BCG Vaccines for Mother and Child","2025-12-31","BCG vaccine",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT04658680","Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?","2026-03","BCG vaccination at first health facility contact",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT04220671","Measles Vaccination at Health System Contacts","2026-12","measles vaccine",{"nctId":50,"briefTitle":51,"date":52,"intervention":38},"NCT05591339","Diabetes Diagnosis, Management, Prevention and Education in Guinea-Bissau","2027-08-01",{"nctId":54,"briefTitle":55,"date":56,"intervention":57},"NCT07005726","BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa","2030-05","BCG Vaccine",[59,60,61,62,63,64],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[66,114,210,229,250,304,343,365,401,436,464,498,534,552,570,588,612,636,662,685,710,737,755,782,800,827,845,871,889,912,934,959,1034,1072,1099,1117,1135,1160],{"intervention":38,"totalTrials":9,"cells":67},{"EARLY_PHASE1":68,"PHASE1":71,"PHASE2":73,"PHASE3":75,"PHASE4":77,"NA":112},{"trials":69,"activeCount":70},[],0,{"trials":72,"activeCount":70},[],{"trials":74,"activeCount":70},[],{"trials":76,"activeCount":70},[],{"trials":78,"activeCount":9,"soonestReadout":37},[79,90,101],{"nctId":54,"briefTitle":55,"status":80,"phases":81,"primaryCompletion":56,"completion":82,"start":83,"enrollment":84,"conditions":85,"interventions":89},"ENROLLING_BY_INVITATION",[63],"2030-07","2025-05-09",6000,[86,26,87,88],"Infant Morbidity","Non-Specific Effects of Vaccines","BCG",[57],{"nctId":50,"briefTitle":51,"status":91,"phases":92,"primaryCompletion":52,"completion":93,"start":94,"enrollment":95,"conditions":96,"interventions":99},"ACTIVE_NOT_RECRUITING",[63],"2029-08-01","2023-12-01",200,[97,98],"Diabetes Mellitus","BCG Vaccination Reaction",[38,100],"Saline placebo",{"nctId":35,"briefTitle":36,"status":102,"phases":103,"primaryCompletion":37,"completion":104,"start":105,"enrollment":106,"conditions":107,"interventions":110},"RECRUITING",[63],"2027-12-31","2021-05-20",2400,[108,23,109,98],"Vaccine Preventable Disease","Mother-Infant Interaction",[38,111],"Measles vaccine",{"trials":113,"activeCount":70},[],{"intervention":111,"totalTrials":21,"cells":115},{"EARLY_PHASE1":116,"PHASE1":118,"PHASE2":120,"PHASE3":122,"PHASE4":124,"NA":196},{"trials":117,"activeCount":70},[],{"trials":119,"activeCount":70},[],{"trials":121,"activeCount":70},[],{"trials":123,"activeCount":70},[],{"trials":125,"activeCount":195,"soonestReadout":37},[126,136,146,161,173,183,187],{"nctId":45,"briefTitle":46,"status":80,"phases":127,"primaryCompletion":47,"completion":128,"start":129,"enrollment":130,"conditions":131,"interventions":135},[63],"2027-06","2020-01-08",5400,[132,133,15,134],"Measles Vaccine","Hospital Admission","Non-specific (Heterologous) Effects of Vaccines",[48],{"nctId":137,"briefTitle":138,"status":139,"phases":140,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":145},"NCT00168558","Early Two-dose Measles Vaccination Trial","COMPLETED",[63],"2008-03","2003-07",5879,[23],[111],{"nctId":147,"briefTitle":148,"status":139,"phases":149,"primaryCompletion":150,"completion":151,"start":152,"enrollment":153,"conditions":154,"interventions":159},"NCT03460002","Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children",[63],"2021-10","2022-08","2016-11",28612,[155,156,157,15,18,158],"Measles Vaccination","Oral Polio Vaccine","Non-specific\u002FHeterologous Effects of Vaccines","Children",[111,160],"Oral polio vaccine",{"nctId":162,"briefTitle":163,"status":139,"phases":164,"completion":165,"start":166,"enrollment":167,"conditions":168,"interventions":172},"NCT00168545","Immunology of Non-specific Effects of Vaccine",[63],"2007-01","2006-01",400,[23,169,170,171],"Diphtheria","Tetanus","Pertussis",[111],{"nctId":174,"briefTitle":175,"status":176,"phases":177,"primaryCompletion":178,"start":179,"conditions":180,"interventions":182},"NCT01486355","Additional Measles Vaccine at 4 Months of Age","UNKNOWN",[63],"2016-07","2011-08",[181],"Measles Infection",[111],{"nctId":35,"briefTitle":36,"status":102,"phases":184,"primaryCompletion":37,"completion":104,"start":105,"enrollment":106,"conditions":185,"interventions":186},[63],[108,23,109,98],[38,111],{"nctId":188,"briefTitle":189,"status":139,"phases":190,"completion":165,"start":191,"enrollment":192,"conditions":193,"interventions":194},"NCT00168571","Long-term Follow-up of Measles Antibodies",[63],"2002-03",1960,[23],[111],2,{"trials":197,"activeCount":70},[198],{"nctId":199,"briefTitle":200,"status":139,"phases":201,"primaryCompletion":202,"completion":203,"start":204,"enrollment":205,"conditions":206,"interventions":209},"NCT02943681","A Second Dose of Measles Vaccine (MV) in the Second Year of Life",[64],"2020-05","2021-05","2016-10",3812,[207,208],"Child Mortality","Child Morbidity",[111],{"intervention":100,"totalTrials":211,"cells":212},1,{"EARLY_PHASE1":213,"PHASE1":215,"PHASE2":217,"PHASE3":219,"PHASE4":221,"NA":227},{"trials":214,"activeCount":70},[],{"trials":216,"activeCount":70},[],{"trials":218,"activeCount":70},[],{"trials":220,"activeCount":70},[],{"trials":222,"activeCount":211,"soonestReadout":52},[223],{"nctId":50,"briefTitle":51,"status":91,"phases":224,"primaryCompletion":52,"completion":93,"start":94,"enrollment":95,"conditions":225,"interventions":226},[63],[97,98],[38,100],{"trials":228,"activeCount":70},[],{"intervention":43,"totalTrials":211,"cells":230},{"EARLY_PHASE1":231,"PHASE1":233,"PHASE2":235,"PHASE3":237,"PHASE4":239,"NA":248},{"trials":232,"activeCount":70},[],{"trials":234,"activeCount":70},[],{"trials":236,"activeCount":70},[],{"trials":238,"activeCount":70},[],{"trials":240,"activeCount":211,"soonestReadout":42},[241],{"nctId":40,"briefTitle":41,"status":91,"phases":242,"primaryCompletion":42,"completion":243,"start":244,"enrollment":245,"conditions":246,"interventions":247},[63],"2026-07","2021-02-25",22800,[26,88],[43],{"trials":249,"activeCount":70},[],{"intervention":251,"totalTrials":9,"cells":252},"BCG-Denmark",{"EARLY_PHASE1":253,"PHASE1":255,"PHASE2":257,"PHASE3":259,"PHASE4":285,"NA":302},{"trials":254,"activeCount":70},[],{"trials":256,"activeCount":70},[],{"trials":258,"activeCount":70},[],{"trials":260,"activeCount":70},[261,274],{"nctId":262,"briefTitle":263,"status":139,"phases":264,"primaryCompletion":265,"completion":266,"start":267,"enrollment":268,"conditions":269,"interventions":272},"NCT04373291","Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic",[62],"2021-07-31","2021-10-01","2020-05-18",1293,[270,30,18,271,32],"COVID-19","Absenteeism",[251,273],"Saline",{"nctId":275,"briefTitle":276,"status":139,"phases":277,"primaryCompletion":278,"completion":278,"start":279,"enrollment":280,"conditions":281,"interventions":284},"NCT04542330","Using BCG to Protect Senior Citizens During the COVID-19 Pandemic",[62],"2023-01-11","2020-09-15",1700,[282,30,32,18,283,108],"Covid19","Immunosenescence",[251,273],{"trials":286,"activeCount":70},[287],{"nctId":288,"briefTitle":289,"status":176,"phases":290,"primaryCompletion":291,"completion":292,"start":293,"enrollment":294,"conditions":295,"interventions":300},"NCT05397678","Trial to Compare BCG-Bulgaria and BCG-Denmark",[63],"2024-07","2024-10","2022-10-21",15000,[296,297,298,299,30],"Death; Neonatal","Death, Infant","Morbidity;Newborn","Morbidity;Infant",[251,301],"BCG-Bulgaria",{"trials":303,"activeCount":70},[],{"intervention":305,"totalTrials":195,"cells":306},"BCG-Japan",{"EARLY_PHASE1":307,"PHASE1":309,"PHASE2":311,"PHASE3":313,"PHASE4":315,"NA":341},{"trials":308,"activeCount":70},[],{"trials":310,"activeCount":70},[],{"trials":312,"activeCount":70},[],{"trials":314,"activeCount":70},[],{"trials":316,"activeCount":70},[317,328],{"nctId":318,"briefTitle":319,"status":139,"phases":320,"primaryCompletion":321,"completion":322,"start":323,"enrollment":324,"conditions":325,"interventions":326},"NCT04383925","Trial to Compare Two Strains of BCG",[63],"2022-10-30","2022-12-01","2020-05-04",16390,[297,299],[305,327],"BCG-Russia",{"nctId":329,"briefTitle":330,"status":139,"phases":331,"primaryCompletion":332,"completion":333,"start":334,"enrollment":335,"conditions":336,"interventions":340},"NCT03400878","Comparing Morbidity and Mortality Effects of Two Different Strains of BCG",[63],"2020-06-01","2020-10-01","2017-10-14",17505,[32,86,26,337,338,339],"Trained Immunity","Vaccine Reaction","Vaccine Adverse Reaction",[305,327],{"trials":342,"activeCount":70},[],{"intervention":327,"totalTrials":195,"cells":344},{"EARLY_PHASE1":345,"PHASE1":347,"PHASE2":349,"PHASE3":351,"PHASE4":353,"NA":363},{"trials":346,"activeCount":70},[],{"trials":348,"activeCount":70},[],{"trials":350,"activeCount":70},[],{"trials":352,"activeCount":70},[],{"trials":354,"activeCount":70},[355,359],{"nctId":318,"briefTitle":319,"status":139,"phases":356,"primaryCompletion":321,"completion":322,"start":323,"enrollment":324,"conditions":357,"interventions":358},[63],[297,299],[305,327],{"nctId":329,"briefTitle":330,"status":139,"phases":360,"primaryCompletion":332,"completion":333,"start":334,"enrollment":335,"conditions":361,"interventions":362},[63],[32,86,26,337,338,339],[305,327],{"trials":364,"activeCount":70},[],{"intervention":366,"totalTrials":195,"cells":367},"chloroquine",{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":399},{"trials":369,"activeCount":70},[],{"trials":371,"activeCount":70},[],{"trials":373,"activeCount":70},[],{"trials":375,"activeCount":70},[],{"trials":377,"activeCount":70},[378,388],{"nctId":379,"briefTitle":380,"status":139,"phases":381,"primaryCompletion":382,"completion":382,"start":383,"enrollment":384,"conditions":385,"interventions":386},"NCT00137514","Chloroquine and Amodiaquine for Treatment of Malaria in Children",[63],"2004-05","2001-03",720,[28],[366,387],"amodiaquine",{"nctId":389,"briefTitle":390,"status":139,"phases":391,"primaryCompletion":392,"completion":392,"start":393,"enrollment":394,"conditions":395,"interventions":396},"NCT00426439","Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau",[63],"2008-11","2006-12",300,[28],[397,398],"Chloroquine","Artemether-lumefantrine",{"trials":400,"activeCount":70},[],{"intervention":402,"totalTrials":195,"cells":403},"Bacille Calmette Guerin",{"EARLY_PHASE1":404,"PHASE1":406,"PHASE2":408,"PHASE3":410,"PHASE4":412,"NA":434},{"trials":405,"activeCount":70},[],{"trials":407,"activeCount":70},[],{"trials":409,"activeCount":70},[],{"trials":411,"activeCount":70},[],{"trials":413,"activeCount":70},[414,425],{"nctId":415,"briefTitle":416,"status":417,"phases":418,"primaryCompletion":419,"completion":420,"start":421,"enrollment":422,"conditions":423,"interventions":424},"NCT00126217","Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine","TERMINATED",[63],"2006-05","2006-09","2002-07",2871,[20],[402],{"nctId":426,"briefTitle":427,"status":139,"phases":428,"primaryCompletion":141,"completion":141,"start":429,"enrollment":430,"conditions":431,"interventions":433},"NCT00146302","Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?",[63],"2002-11",2320,[432],"Tuberculosis",[402],{"trials":435,"activeCount":70},[],{"intervention":398,"totalTrials":195,"cells":437},{"EARLY_PHASE1":438,"PHASE1":440,"PHASE2":442,"PHASE3":444,"PHASE4":446,"NA":462},{"trials":439,"activeCount":70},[],{"trials":441,"activeCount":70},[],{"trials":443,"activeCount":70},[],{"trials":445,"activeCount":70},[],{"trials":447,"activeCount":70},[448,458],{"nctId":449,"briefTitle":450,"status":139,"phases":451,"primaryCompletion":452,"completion":178,"start":453,"enrollment":454,"conditions":455,"interventions":456},"NCT01704508","Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A",[63],"2015-10","2012-11",346,[20],[398,457],"Dihydroartemisinin-piperaquine",{"nctId":389,"briefTitle":390,"status":139,"phases":459,"primaryCompletion":392,"completion":392,"start":393,"enrollment":394,"conditions":460,"interventions":461},[63],[28],[397,398],{"trials":463,"activeCount":70},[],{"intervention":465,"totalTrials":195,"cells":466},"Early measles vaccine",{"EARLY_PHASE1":467,"PHASE1":469,"PHASE2":471,"PHASE3":473,"PHASE4":475,"NA":496},{"trials":468,"activeCount":70},[],{"trials":470,"activeCount":70},[],{"trials":472,"activeCount":70},[],{"trials":474,"activeCount":70},[],{"trials":476,"activeCount":70},[477,486],{"nctId":478,"briefTitle":479,"status":139,"phases":480,"primaryCompletion":481,"completion":204,"start":482,"enrollment":483,"conditions":484,"interventions":485},"NCT01644721","Trial of Additional Measles Vaccine to Reduce Child Mortality",[63],"2016-06","2012-07",3750,[132],[465],{"nctId":487,"briefTitle":488,"status":139,"phases":489,"primaryCompletion":490,"completion":491,"start":492,"enrollment":493,"conditions":494,"interventions":495},"NCT01668745","Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.",[63],"2015-12-31","2016-06-15","2013-05-03",4559,[132],[465],{"trials":497,"activeCount":70},[],{"intervention":499,"totalTrials":195,"cells":500},"BCG-Denmark 1331",{"EARLY_PHASE1":501,"PHASE1":503,"PHASE2":505,"PHASE3":507,"PHASE4":509,"NA":532},{"trials":502,"activeCount":70},[],{"trials":504,"activeCount":70},[],{"trials":506,"activeCount":70},[],{"trials":508,"activeCount":70},[],{"trials":510,"activeCount":70},[511,520],{"nctId":512,"briefTitle":513,"status":417,"phases":514,"primaryCompletion":515,"completion":515,"start":516,"enrollment":517,"conditions":518,"interventions":519},"NCT02504203","Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial",[63],"2021-06","2015-11",2332,[26,88],[499],{"nctId":521,"briefTitle":522,"status":139,"phases":523,"primaryCompletion":524,"completion":525,"start":526,"enrollment":527,"conditions":528,"interventions":530},"NCT02447536","Trial of Two Strains of BCG",[63],"2017-11-24","2018-05-01","2014-12-08",12006,[18,529],"Bacille Calmette-Guérin",[499,531],"BCG-Russia-I",{"trials":533,"activeCount":70},[],{"intervention":387,"totalTrials":211,"cells":535},{"EARLY_PHASE1":536,"PHASE1":538,"PHASE2":540,"PHASE3":542,"PHASE4":544,"NA":550},{"trials":537,"activeCount":70},[],{"trials":539,"activeCount":70},[],{"trials":541,"activeCount":70},[],{"trials":543,"activeCount":70},[],{"trials":545,"activeCount":70},[546],{"nctId":379,"briefTitle":380,"status":139,"phases":547,"primaryCompletion":382,"completion":382,"start":383,"enrollment":384,"conditions":548,"interventions":549},[63],[28],[366,387],{"trials":551,"activeCount":70},[],{"intervention":457,"totalTrials":211,"cells":553},{"EARLY_PHASE1":554,"PHASE1":556,"PHASE2":558,"PHASE3":560,"PHASE4":562,"NA":568},{"trials":555,"activeCount":70},[],{"trials":557,"activeCount":70},[],{"trials":559,"activeCount":70},[],{"trials":561,"activeCount":70},[],{"trials":563,"activeCount":70},[564],{"nctId":449,"briefTitle":450,"status":139,"phases":565,"primaryCompletion":452,"completion":178,"start":453,"enrollment":454,"conditions":566,"interventions":567},[63],[20],[398,457],{"trials":569,"activeCount":70},[],{"intervention":301,"totalTrials":211,"cells":571},{"EARLY_PHASE1":572,"PHASE1":574,"PHASE2":576,"PHASE3":578,"PHASE4":580,"NA":586},{"trials":573,"activeCount":70},[],{"trials":575,"activeCount":70},[],{"trials":577,"activeCount":70},[],{"trials":579,"activeCount":70},[],{"trials":581,"activeCount":70},[582],{"nctId":288,"briefTitle":289,"status":176,"phases":583,"primaryCompletion":291,"completion":292,"start":293,"enrollment":294,"conditions":584,"interventions":585},[63],[296,297,298,299,30],[251,301],{"trials":587,"activeCount":70},[],{"intervention":589,"totalTrials":211,"cells":590},"acetaminophen",{"EARLY_PHASE1":591,"PHASE1":593,"PHASE2":595,"PHASE3":597,"PHASE4":599,"NA":610},{"trials":592,"activeCount":70},[],{"trials":594,"activeCount":70},[],{"trials":596,"activeCount":70},[],{"trials":598,"activeCount":70},[],{"trials":600,"activeCount":70},[601],{"nctId":602,"briefTitle":603,"status":176,"phases":604,"primaryCompletion":605,"completion":606,"start":382,"conditions":607,"interventions":609},"NCT00137566","The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau",[63],"2006-11","2010-01",[20,608],"Falciparum",[589],{"trials":611,"activeCount":70},[],{"intervention":613,"totalTrials":211,"cells":614},"Sulfadoxine-pyrimethamine",{"EARLY_PHASE1":615,"PHASE1":617,"PHASE2":619,"PHASE3":621,"PHASE4":623,"NA":634},{"trials":616,"activeCount":70},[],{"trials":618,"activeCount":70},[],{"trials":620,"activeCount":70},[],{"trials":622,"activeCount":70},[],{"trials":624,"activeCount":70},[625],{"nctId":626,"briefTitle":627,"status":139,"phases":628,"completion":629,"start":630,"enrollment":631,"conditions":632,"interventions":633},"NCT00137553","The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children",[63],"2004-03","2001-05",60,[28],[613],{"trials":635,"activeCount":70},[],{"intervention":637,"totalTrials":211,"cells":638},"DTP3\u002F4+OPV+MV versus OPV+MV or DTP4+OPV4 versus OPV4",{"EARLY_PHASE1":639,"PHASE1":641,"PHASE2":643,"PHASE3":645,"PHASE4":647,"NA":660},{"trials":640,"activeCount":70},[],{"trials":642,"activeCount":70},[],{"trials":644,"activeCount":70},[],{"trials":646,"activeCount":70},[],{"trials":648,"activeCount":70},[649],{"nctId":650,"briefTitle":651,"status":139,"phases":652,"primaryCompletion":653,"completion":653,"start":654,"enrollment":655,"conditions":656,"interventions":659},"NCT00244673","Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination",[63],"2011-12","2005-10",6534,[15,657,658],"Hospitalization","Adverse Events",[637],{"trials":661,"activeCount":70},[],{"intervention":663,"totalTrials":211,"cells":664},"Measles and inactivated polio vaccine",{"EARLY_PHASE1":665,"PHASE1":667,"PHASE2":669,"PHASE3":671,"PHASE4":673,"NA":683},{"trials":666,"activeCount":70},[],{"trials":668,"activeCount":70},[],{"trials":670,"activeCount":70},[],{"trials":672,"activeCount":70},[],{"trials":674,"activeCount":70},[675],{"nctId":676,"briefTitle":677,"status":139,"phases":678,"primaryCompletion":166,"completion":166,"start":679,"enrollment":680,"conditions":681,"interventions":682},"NCT00168662","Non-Specific Effects of Standard Titre Measles Vaccination",[63],"1995-03",7800,[23],[663],{"trials":684,"activeCount":70},[],{"intervention":686,"totalTrials":211,"cells":687},"Providing measles vaccine for all children 9-35 months who have not yet received a routine measles vaccine",{"EARLY_PHASE1":688,"PHASE1":690,"PHASE2":692,"PHASE3":694,"PHASE4":696,"NA":708},{"trials":689,"activeCount":70},[],{"trials":691,"activeCount":70},[],{"trials":693,"activeCount":70},[],{"trials":695,"activeCount":70},[],{"trials":697,"activeCount":70},[698],{"nctId":699,"briefTitle":700,"status":139,"phases":701,"primaryCompletion":702,"completion":702,"start":703,"enrollment":704,"conditions":705,"interventions":707},"NCT01306006","The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age",[63],"2017-12-02","2011-02",3500,[15,706],"Vaccines",[686],{"trials":709,"activeCount":70},[],{"intervention":711,"totalTrials":211,"cells":712},"oral polio vaccine + information",{"EARLY_PHASE1":713,"PHASE1":715,"PHASE2":717,"PHASE3":719,"PHASE4":721,"NA":735},{"trials":714,"activeCount":70},[],{"trials":716,"activeCount":70},[],{"trials":718,"activeCount":70},[],{"trials":720,"activeCount":70},[],{"trials":722,"activeCount":70},[723],{"nctId":724,"briefTitle":725,"status":139,"phases":726,"primaryCompletion":727,"completion":728,"start":729,"enrollment":730,"conditions":731,"interventions":734},"NCT04445428","OPV as Potential Protection Against COVID-19",[63],"2022-01-31","2022-06-15","2020-07-15",3729,[732,733,15,18,87],"Poliovirus Vaccine, Oral","COVID",[711],{"trials":736,"activeCount":70},[],{"intervention":531,"totalTrials":211,"cells":738},{"EARLY_PHASE1":739,"PHASE1":741,"PHASE2":743,"PHASE3":745,"PHASE4":747,"NA":753},{"trials":740,"activeCount":70},[],{"trials":742,"activeCount":70},[],{"trials":744,"activeCount":70},[],{"trials":746,"activeCount":70},[],{"trials":748,"activeCount":70},[749],{"nctId":521,"briefTitle":522,"status":139,"phases":750,"primaryCompletion":524,"completion":525,"start":526,"enrollment":527,"conditions":751,"interventions":752},[63],[18,529],[499,531],{"trials":754,"activeCount":70},[],{"intervention":756,"totalTrials":211,"cells":757},"Dihydroartemisinin-piperaquine 160 mg\u002F20 mg Oral",{"EARLY_PHASE1":758,"PHASE1":760,"PHASE2":762,"PHASE3":764,"PHASE4":766,"NA":780},{"trials":759,"activeCount":70},[],{"trials":761,"activeCount":70},[],{"trials":763,"activeCount":70},[],{"trials":765,"activeCount":70},[],{"trials":767,"activeCount":70},[768],{"nctId":769,"briefTitle":770,"status":139,"phases":771,"primaryCompletion":772,"completion":773,"start":774,"enrollment":775,"conditions":776,"interventions":778},"NCT04897919","Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria",[63],"2017-10-01","2018-12-01","2015-08-01",474,[20,777],"Effectiveness",[756,779],"Artemether-Lumefantrine 20 Mg-120 Mg Oral",{"trials":781,"activeCount":70},[],{"intervention":779,"totalTrials":211,"cells":783},{"EARLY_PHASE1":784,"PHASE1":786,"PHASE2":788,"PHASE3":790,"PHASE4":792,"NA":798},{"trials":785,"activeCount":70},[],{"trials":787,"activeCount":70},[],{"trials":789,"activeCount":70},[],{"trials":791,"activeCount":70},[],{"trials":793,"activeCount":70},[794],{"nctId":769,"briefTitle":770,"status":139,"phases":795,"primaryCompletion":772,"completion":773,"start":774,"enrollment":775,"conditions":796,"interventions":797},[63],[20,777],[756,779],{"trials":799,"activeCount":70},[],{"intervention":801,"totalTrials":211,"cells":802},"Bacille Calmette-Guerin",{"EARLY_PHASE1":803,"PHASE1":805,"PHASE2":807,"PHASE3":809,"PHASE4":811,"NA":825},{"trials":804,"activeCount":70},[],{"trials":806,"activeCount":70},[],{"trials":808,"activeCount":70},[],{"trials":810,"activeCount":70},[],{"trials":812,"activeCount":70},[813],{"nctId":814,"briefTitle":815,"status":139,"phases":816,"primaryCompletion":817,"completion":818,"start":819,"enrollment":820,"conditions":821,"interventions":823},"NCT02953327","Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau",[63],"2017-06-15","2020-06-15","2017-02-01",40,[822,529],"Innate Immunity",[801,824],"BCG solvent",{"trials":826,"activeCount":70},[],{"intervention":824,"totalTrials":211,"cells":828},{"EARLY_PHASE1":829,"PHASE1":831,"PHASE2":833,"PHASE3":835,"PHASE4":837,"NA":843},{"trials":830,"activeCount":70},[],{"trials":832,"activeCount":70},[],{"trials":834,"activeCount":70},[],{"trials":836,"activeCount":70},[],{"trials":838,"activeCount":70},[839],{"nctId":814,"briefTitle":815,"status":139,"phases":840,"primaryCompletion":817,"completion":818,"start":819,"enrollment":820,"conditions":841,"interventions":842},[63],[822,529],[801,824],{"trials":844,"activeCount":70},[],{"intervention":846,"totalTrials":211,"cells":847},"Chloroquine-base 50 mg",{"EARLY_PHASE1":848,"PHASE1":850,"PHASE2":852,"PHASE3":854,"PHASE4":856,"NA":869},{"trials":849,"activeCount":70},[],{"trials":851,"activeCount":70},[],{"trials":853,"activeCount":70},[],{"trials":855,"activeCount":70},[],{"trials":857,"activeCount":70},[858],{"nctId":859,"briefTitle":860,"status":139,"phases":861,"primaryCompletion":862,"completion":863,"start":864,"enrollment":865,"conditions":866,"interventions":867},"NCT01814423","Pharmacokinetic Study of Multi-dose Chloroquine",[63],"2014-02","2014-03","2013-04",30,[20],[846,868],"Chloroquine-base 70 mg",{"trials":870,"activeCount":70},[],{"intervention":868,"totalTrials":211,"cells":872},{"EARLY_PHASE1":873,"PHASE1":875,"PHASE2":877,"PHASE3":879,"PHASE4":881,"NA":887},{"trials":874,"activeCount":70},[],{"trials":876,"activeCount":70},[],{"trials":878,"activeCount":70},[],{"trials":880,"activeCount":70},[],{"trials":882,"activeCount":70},[883],{"nctId":859,"briefTitle":860,"status":139,"phases":884,"primaryCompletion":862,"completion":863,"start":864,"enrollment":865,"conditions":885,"interventions":886},[63],[20],[846,868],{"trials":888,"activeCount":70},[],{"intervention":88,"totalTrials":211,"cells":890},{"EARLY_PHASE1":891,"PHASE1":893,"PHASE2":895,"PHASE3":897,"PHASE4":899,"NA":910},{"trials":892,"activeCount":70},[],{"trials":894,"activeCount":70},[],{"trials":896,"activeCount":70},[],{"trials":898,"activeCount":70},[],{"trials":900,"activeCount":70},[901],{"nctId":902,"briefTitle":903,"status":417,"phases":904,"primaryCompletion":772,"completion":772,"start":905,"enrollment":906,"conditions":907,"interventions":909},"NCT01989026","A Randomized Trial of Providing BCG Vaccination Immediately",[63],"2013-10",3361,[908],"Early Neonatal Mortality",[88],{"trials":911,"activeCount":70},[],{"intervention":273,"totalTrials":195,"cells":913},{"EARLY_PHASE1":914,"PHASE1":916,"PHASE2":918,"PHASE3":920,"PHASE4":930,"NA":932},{"trials":915,"activeCount":70},[],{"trials":917,"activeCount":70},[],{"trials":919,"activeCount":70},[],{"trials":921,"activeCount":70},[922,926],{"nctId":262,"briefTitle":263,"status":139,"phases":923,"primaryCompletion":265,"completion":266,"start":267,"enrollment":268,"conditions":924,"interventions":925},[62],[270,30,18,271,32],[251,273],{"nctId":275,"briefTitle":276,"status":139,"phases":927,"primaryCompletion":278,"completion":278,"start":279,"enrollment":280,"conditions":928,"interventions":929},[62],[282,30,32,18,283,108],[251,273],{"trials":931,"activeCount":70},[],{"trials":933,"activeCount":70},[],{"intervention":935,"totalTrials":211,"cells":936},"Sulfamethoxazole-Trimethoprim",{"EARLY_PHASE1":937,"PHASE1":939,"PHASE2":941,"PHASE3":943,"PHASE4":955,"NA":957},{"trials":938,"activeCount":70},[],{"trials":940,"activeCount":70},[],{"trials":942,"activeCount":70},[],{"trials":944,"activeCount":70},[945],{"nctId":946,"briefTitle":947,"status":139,"phases":948,"primaryCompletion":949,"completion":949,"start":950,"enrollment":951,"conditions":952,"interventions":954},"NCT00168532","Prophylactic Antibiotics in Measles",[62],"2001-10","1998-01",218,[953,23],"Post-Measles Pneumonia",[935],{"trials":956,"activeCount":70},[],{"trials":958,"activeCount":70},[],{"intervention":960,"totalTrials":24,"cells":961},"Vitamin A",{"EARLY_PHASE1":962,"PHASE1":964,"PHASE2":966,"PHASE3":968,"PHASE4":970,"NA":1022},{"trials":963,"activeCount":70},[],{"trials":965,"activeCount":70},[],{"trials":967,"activeCount":70},[],{"trials":969,"activeCount":70},[],{"trials":971,"activeCount":70},[972,981,988,996,1003,1013],{"nctId":973,"briefTitle":974,"status":139,"phases":975,"primaryCompletion":976,"start":977,"enrollment":978,"conditions":979,"interventions":980},"NCT00168597","Vitamin A With BCG Vaccine",[63],"2013-11","2002-08",4800,[15,18],[960],{"nctId":982,"briefTitle":983,"status":139,"phases":984,"completion":985,"start":429,"enrollment":130,"conditions":986,"interventions":987},"NCT00168584","Different Doses of Vitamin A and Childhood Morbidity and Mortality",[63],"2003-08",[15,18],[960],{"nctId":989,"briefTitle":990,"status":176,"phases":991,"start":992,"enrollment":993,"conditions":994,"interventions":995},"NCT00168610","Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine",[63],"2004-11",7600,[26,18],[960],{"nctId":997,"briefTitle":998,"status":139,"phases":999,"primaryCompletion":976,"start":992,"enrollment":1000,"conditions":1001,"interventions":1002},"NCT00168636","Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality",[63],11000,[15,18],[960],{"nctId":1004,"briefTitle":1005,"status":417,"phases":1006,"primaryCompletion":1007,"completion":1008,"start":1009,"enrollment":1010,"conditions":1011,"interventions":1012},"NCT00514891","Impact of the WHO Recommended Vitamin A Supplementation at Immunisation Contacts",[63],"2012-06","2012-12","2007-08",9500,[15,18],[960],{"nctId":1014,"briefTitle":1015,"status":176,"phases":1016,"completion":1017,"start":1018,"enrollment":1019,"conditions":1020,"interventions":1021},"NCT00168623","Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity",[63],"2014-12","2003-11",6200,[15,18],[960],{"trials":1023,"activeCount":70},[1024],{"nctId":1025,"briefTitle":1026,"status":176,"phases":1027,"completion":1028,"start":1029,"enrollment":820,"conditions":1030,"interventions":1033},"NCT00168649","Vitamin A and Response to Endotoxin",[64],"2014-06","2005-06",[1031,1032],"TNF-alfa","Endotoxin Levels",[960],{"intervention":160,"totalTrials":9,"cells":1035},{"EARLY_PHASE1":1036,"PHASE1":1038,"PHASE2":1040,"PHASE3":1042,"PHASE4":1044,"NA":1060},{"trials":1037,"activeCount":70},[],{"trials":1039,"activeCount":70},[],{"trials":1041,"activeCount":70},[],{"trials":1043,"activeCount":70},[],{"trials":1045,"activeCount":70},[1046,1056],{"nctId":1047,"briefTitle":1048,"status":176,"phases":1049,"primaryCompletion":1050,"completion":1051,"start":1052,"enrollment":1053,"conditions":1054,"interventions":1055},"NCT06266754","The Non-Specific Immunological Effects of Providing Oral Polio Vaccine to Seniors in Guinea-Bissau",[63],"2024-07-31","2024-12-31","2024-01-29",80,[338],[160],{"nctId":147,"briefTitle":148,"status":139,"phases":1057,"primaryCompletion":150,"completion":151,"start":152,"enrollment":153,"conditions":1058,"interventions":1059},[63],[155,156,157,15,18,158],[111,160],{"trials":1061,"activeCount":70},[1062],{"nctId":1063,"briefTitle":1064,"status":176,"phases":1065,"primaryCompletion":1028,"completion":1066,"start":1067,"conditions":1068,"interventions":1071},"NCT00710983","Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth",[64],"2015-01","2008-07",[1069,1070],"Infant, Newborn","Healthy",[160],{"intervention":1073,"totalTrials":211,"cells":1074},"RQ1a: Delayed vs. timely vaccination with the 1st dose of DTaP-IPV-Hib",{"EARLY_PHASE1":1075,"PHASE1":1077,"PHASE2":1079,"PHASE3":1081,"PHASE4":1083,"NA":1085},{"trials":1076,"activeCount":70},[],{"trials":1078,"activeCount":70},[],{"trials":1080,"activeCount":70},[],{"trials":1082,"activeCount":70},[],{"trials":1084,"activeCount":70},[],{"trials":1086,"activeCount":70},[1087],{"nctId":1088,"briefTitle":1089,"status":139,"phases":1090,"primaryCompletion":1091,"completion":1091,"start":1092,"enrollment":1093,"conditions":1094,"interventions":1096},"NCT03142139","Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age?",[],"2014-12-31","1997-01-01",1027559,[1095],"Atopic Dermatitis",[1073,1097,1098],"RQ1b: Delayed vs. timely vaccination with the 2nd dose of DTaP-IPV-Hib","RQ2: Vaccination with DTaP-IPV-Hib compared to being unvaccinated",{"intervention":1097,"totalTrials":211,"cells":1100},{"EARLY_PHASE1":1101,"PHASE1":1103,"PHASE2":1105,"PHASE3":1107,"PHASE4":1109,"NA":1111},{"trials":1102,"activeCount":70},[],{"trials":1104,"activeCount":70},[],{"trials":1106,"activeCount":70},[],{"trials":1108,"activeCount":70},[],{"trials":1110,"activeCount":70},[],{"trials":1112,"activeCount":70},[1113],{"nctId":1088,"briefTitle":1089,"status":139,"phases":1114,"primaryCompletion":1091,"completion":1091,"start":1092,"enrollment":1093,"conditions":1115,"interventions":1116},[],[1095],[1073,1097,1098],{"intervention":1098,"totalTrials":211,"cells":1118},{"EARLY_PHASE1":1119,"PHASE1":1121,"PHASE2":1123,"PHASE3":1125,"PHASE4":1127,"NA":1129},{"trials":1120,"activeCount":70},[],{"trials":1122,"activeCount":70},[],{"trials":1124,"activeCount":70},[],{"trials":1126,"activeCount":70},[],{"trials":1128,"activeCount":70},[],{"trials":1130,"activeCount":70},[1131],{"nctId":1088,"briefTitle":1089,"status":139,"phases":1132,"primaryCompletion":1091,"completion":1091,"start":1092,"enrollment":1093,"conditions":1133,"interventions":1134},[],[1095],[1073,1097,1098],{"intervention":1136,"totalTrials":211,"cells":1137},"OPV",{"EARLY_PHASE1":1138,"PHASE1":1140,"PHASE2":1142,"PHASE3":1144,"PHASE4":1146,"NA":1148},{"trials":1139,"activeCount":70},[],{"trials":1141,"activeCount":70},[],{"trials":1143,"activeCount":70},[],{"trials":1145,"activeCount":70},[],{"trials":1147,"activeCount":70},[],{"trials":1149,"activeCount":70},[1150],{"nctId":1151,"briefTitle":1152,"status":139,"phases":1153,"start":1154,"conditions":1155,"interventions":1158},"NCT00625482","Sex-Differential Health Interventions In Low-Birth-Weight Infants",[64],"2008-02",[15,18,1156,1157],"Growth","Neonatal Mortality",[1136,1159,1136,1159],"OPV plus BCG",{"intervention":1159,"totalTrials":211,"cells":1161},{"EARLY_PHASE1":1162,"PHASE1":1164,"PHASE2":1166,"PHASE3":1168,"PHASE4":1170,"NA":1172},{"trials":1163,"activeCount":70},[],{"trials":1165,"activeCount":70},[],{"trials":1167,"activeCount":70},[],{"trials":1169,"activeCount":70},[],{"trials":1171,"activeCount":70},[],{"trials":1173,"activeCount":70},[1174],{"nctId":1151,"briefTitle":1152,"status":139,"phases":1175,"start":1154,"conditions":1176,"interventions":1177},[64],[15,18,1156,1157],[1136,1159,1136,1159]]